Literature DB >> 2495075

Gonadotrophin releasing hormone analogues for gynaecological disorders and infertility.

H M Fraser, J Waxman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495075      PMCID: PMC1835775          DOI: 10.1136/bmj.298.6672.475

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

1.  Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

Authors:  W H Matta; R W Shaw; R Hesp; D Katz
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

2.  Ovarian stimulation for in-vitro fertilization combining administration of gonadotrophins and blockade of the pituitary with D-Trp6-LHRH microcapsules: pilot studies with two protocols.

Authors:  J R Zorn; M Barata; C Brami; S Epelboin; C Nathan; G Papageorgiou; P Quantin; F Rolet; M Savale; P Boyer
Journal:  Hum Reprod       Date:  1988-02       Impact factor: 6.918

3.  Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.

Authors:  R N Porter; W Smith; I L Craft; N A Abdulwahid; H S Jacobs
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

4.  Goserelin therapy before surgery for uterine fibroids.

Authors:  M A Lumsden; C P West; D T Baird
Journal:  Lancet       Date:  1987-01-03       Impact factor: 79.321

5.  An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months.

Authors:  H M Fraser; J Sandow; H Seidel; W von Rechenberg
Journal:  Acta Endocrinol (Copenh)       Date:  1987-08

6.  Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.

Authors:  A Lanzone; A M Fulghesu; M A Spina; R Apa; E Menini; A Caruso; S Mancuso
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

7.  The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes.

Authors:  J Bancroft; H Boyle; P Warner; H M Fraser
Journal:  Clin Endocrinol (Oxf)       Date:  1987-08       Impact factor: 3.478

8.  Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization.

Authors:  S Neveu; B Hedon; J Bringer; J M Chinchole; F Arnal; C Humeau; P Cristol; J L Viala
Journal:  Fertil Steril       Date:  1987-04       Impact factor: 7.329

9.  Immunosuppressive effects of danazol in vitro.

Authors:  J A Hill; R L Barbieri; D J Anderson
Journal:  Fertil Steril       Date:  1987-09       Impact factor: 7.329

10.  Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.

Authors:  C P West; M A Lumsden; S Lawson; J Williamson; D T Baird
Journal:  Fertil Steril       Date:  1987-07       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.